Heat shock proteins in glioblastomas
/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications /von 2010-01-01 / Neurosurg. Clin. N. Am. 2010 Jan;21(1):111-23Towards a standardized protocol for the generation of monocyte-derived dendritic cell vaccines
/in Dendritic Cells, International Publications /von 2010-01-01 / Methods Mol. Biol. 2010;595:149-63Personalized dendritic cell-based tumor immunotherapy
/in Dendritic Cells, International Publications /von 2010-01-01 / Immunotherapy 2010 Jan;2(1):57-68Clinical applications of a peptide-based vaccine for glioblastoma
/in Dendritic Cells, Glioblastoma, International Publications /von 2010-01-01 / Neurosurg. Clin. N. Am. 2010 Jan;21(1):95-109Dendritic cell vaccines for brain tumors
/in Dendritic Cells, Glioblastoma, International Publications /von 2010-01-01 / Neurosurg. Clin. N. Am. 2010 Jan;21(1):139-57Generation of myeloma-specific T cells using dendritic cells loaded with MUC1- and hTERT- drived nonapeptides or myeloma cell apoptotic bodies
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2010-01-01 / Neoplasma 2010;57(5):455-64Clinical Benefit of Allogeneic Melanoma Cell Lysate-Pulsed Autologous Dendritic Cell Vaccine in MAGE-Positive Colorectal Cancer Patients
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2009-12-15 / Clin. Cancer Res. 2009 Dec;15(24):7726-7736Dendritic cells for active anti-cancer immunotherapy: targeting activation pathways through genetic modification
/in Dendritic Cells, International Publications /von 2009-12-01 / Endocr Metab Immune Disord Drug Targets 2009 Dec;9(4):328-43The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2009-12-01 / Cancer Treat. Rev. 2010 Apr;36(2):131-41
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution